BridgeMD
New treatment option for Breast Cancer
Official title Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
ClinicalTrials.gov ID: NCT06677944
What this study is testing
- What it's testing
- In the management of early breast cancer patients, postoperative radiotherapy following breast-conserving surgery has been established as the standard treatment. Over the past two decades, significant changes have occurred in radiotherapy for breast cancer, encompassing dose fractionation methods, radiotherapy techniques, and delineation of the radiation field.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 2 years
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 and older, women only
You may be able to join if
- Histologically confirmed ductal carcinoma in situ (DCIS) and invasive breast cancer.
- Age ≥ 45
- cT1/cN0, tumor size ≤ 2.5cm
- ECOG 0\~2 -ER+, HER2-
You likely can't join if
- Tumor located too close to the skin or chest wall (within 5 mm)
- With previous treatment history for breast cancer
- Neoadjuvant chemotherapy
- Multicentric disease
- Diffuse microcalcification
- BRCA mutation
See the full eligibility criteria
- Histologically confirmed ductal carcinoma in situ (DCIS) and invasive breast cancer.
- Age ≥ 45
- cT1/cN0, tumor size ≤ 2.5cm
- ECOG 0\~2 -ER+, HER2-
- Tumor located too close to the skin or chest wall (within 5 mm)
- With previous treatment history for breast cancer
- Neoadjuvant chemotherapy
- Multicentric disease
- Diffuse microcalcification
- BRCA mutation
- Paget's disease
- In cases where tumor delineation is not achievable on CT/MRI images
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 45 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.